- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04211025
Screening for Poverty and Related Social Determinants to Improve Knowledge of and Links to Resources (SPARK) Pilot Study (SPARK Pilot)
Screening for Poverty and Related Social Determinants and Intervening to Improve Knowledge of and Links to Resources (SPARK) Pilot Study
Research question and objectives This pilot study will help us answer the following research question: Is it feasible to conduct a large cluster randomized controlled trial (RCT) of an intervention that consists of routine screening for poverty and related social determinants and intervening in Canadian primary care clinics, and what is the sample size required?
Our objectives include:
- to collect data on the feasibility of recruiting clinics for a large cluster randomized controlled trial (RCT)
- to collect data on the acceptability and feasibility of integrating a standardized socio-demographic data collection tool, including screening for poverty, within diverse primary care clinic workflows
- collect data on the acceptability and feasibility of "modest" and "intensive" interventions on poverty (discussed below)
- collect data on the recruitment rate of patients, to assist with calculating the sample size for a larger cluster RCT
- collect data on the intervention effect size of the "modest" and "intensive" interventions on income and health outcomes to assist with calculating the sample size for a larger cluster RCT .
Study Overview
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Ontario
-
Kingston, Ontario, Canada, K7L 5E9
- Queen's Family Health Team
-
Scarborough, Ontario, Canada, M1J 2H3
- Platinum Medical Clinic
-
Toronto, Ontario, Canada, M2K 2W2
- New Family Medicine Network, North York Family Health Team
-
Toronto, Ontario, Canada, M4C 5T2
- Southeast Toronto Family Health Team
-
Toronto, Ontario, Canada, M4L 1G4
- East End Community Health Centre
-
Toronto, Ontario, Canada, M6N 4B4
- Access Alliance
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
Patients: The inclusion criteria are as follows:
- A patient who completed the sociodemographic and social needs survey in their primary care organization.
- Answers "Yes" to the question "Do you have difficulty making ends meet at the end of the month?" and answers "Yes" to the question "Our clinic is part of a study of how to help patients who may be eligible for financial benefits. Would you like to take part?"
- Able to provide consent
- Age is greater than or equal to 18
- Able to converse in English
- Able to be reached via telephone, email, or through coordination with their clinic site
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Screening
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Modest
This approach is feasible to integrate into workflows of a wide-range of clinics, and should have a minimal impact on human resources.
Materials and strategies to support staff in this work will be provided. .
|
The modest intervention consists of a 30-minute appointment (by phone or in-person) with the designated staff using the Benefits Screening Tool , and a plan is developed.
At 4 weeks, the designated staff follows-up with a phone call or email.
|
|
Experimental: Intensive
This approach is more robust, and requires a greater commitment of human resources.
|
The intensive intervention consists of a 30-minute appointment with the designated staff using the Benefits Screening Tool , and a plan is developed.
At 4 weeks, a follow-up appointment is booked for 30 minutes, and progress on the plan is assessed.
At 12 weeks after the initial meeting, the designated staff follows-up with a phone call or email.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Access to Additional Benefits
Time Frame: 2 months follow-up
|
The primary outcome measure will be whether or not participants accessed additional benefits and/or increased income as a result of participating in the study.
This will be determined through the phone surveys with participants, conducted by the study team
|
2 months follow-up
|
|
Access to Additional Benefits
Time Frame: 4 months follow-up
|
The primary outcome measure will be whether or not participants accessed additional benefits and/or increased income as a result of participating in the study.
This will be determined through the phone surveys with participants, conducted by the study team
|
4 months follow-up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Implementation data (sociodemographic and social needs survey)
Time Frame: Through study completion, up to 1 year
|
Number of people completing the sociodemographic and social needs survey
|
Through study completion, up to 1 year
|
|
Implementation data (income screening question)
Time Frame: Through study completion, up to 1 year
|
Number of people who answer positively to the income screening question
|
Through study completion, up to 1 year
|
|
Implementation data (income assistance indication)
Time Frame: Through study completion, up to 1 year
|
Number of people who answer indicate they would like assistance with income
|
Through study completion, up to 1 year
|
|
Implementation data (recruitment and staff time)
Time Frame: Through study completion, up to 1 year
|
Number of people recruited to the study; time required for staff to complete the Benefit Screening Tool and follow-up
|
Through study completion, up to 1 year
|
|
Implementation data (staff time)
Time Frame: Through study completion, up to 1 year
|
Time required for staff to complete the Benefit Screening Tool and follow-up
|
Through study completion, up to 1 year
|
|
Patient self-reported stress as part of qualitative interview
Time Frame: 2 months follow-up
|
Stress Levels (Never, Rarely, Sometimes, Often, Always)
|
2 months follow-up
|
|
Patient self-reported quality of life on the PROMIS Global 10 Generic Health Questionnaire
Time Frame: 2 months follow-up
|
Quality of Life (Excellent, Very Good, Good, Fair, Poor)
|
2 months follow-up
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Andrew D Pinto, MD MSc, Unity Health Toronto
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- Project ID 1532
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.